The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates.

With an emphasis on biologics, and built with the field's leading minds from the likes of Biogen, Genentech, Armagen & Denali, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development.